Bristol-Myers Squibb



Ebit Alterar Data
AbbVie USD 5.24B 1.5B 2024-12
Abbott USD 2.66B 805M 2024-12
ALKERMES USD 162.69M 46.46M 2024-12
Amgen USD 4.03B 11M 2024-12
AstraZeneca USD 4.2B 119M 2024-12
Biogen USD 644.1M 100.9M 2024-12
Bristol-Myers Squibb USD 4.21B 500M 2024-12
Drreddys Laboratories INR 18.02B 1.22B 2024-12
Eli Lilly USD 5.63B 3.88B 2024-12
Gilead Sciences USD 3.11B 144M 2024-12
GlaxoSmithKline GBP 1.43B 1.33B 2024-12
J&J USD 5.35B 1.14B 2024-12
Medtronic USD 2.17B 128M 2025-01
Merck USD 5.22B 339M 2024-12
Novartis USD 4.86B 286M 2024-12
Novo Nordisk 33.82B 7.89B 2024-09
Perrigo USD 193.9M 11.5M 2024-12
Pfizer USD 4.62B 2.42B 2024-12
Prestige Brands USD 91.96M 7.62M 2024-12
Regeneron Pharmaceuticals USD 1.57B 67.9M 2024-12
Roche Holding CHF 11.29B 2.68B 2024-06
Sanofi EUR 2.08B 1.69B 2024-12
Sanofi EUR 2.22B 2.84B 2024-12
United Therapeutics USD 357.7M 14.6M 2024-12
Zoetis USD 988M 30M 2024-12



Bristol-Myers Squibb - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.